A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women With Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy

Trial Profile

A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women With Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Tamoxifen (Primary) ; Antineoplastics; Exemestane; Triptorelin
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms PERCHE
  • Most Recent Events

    • 12 Jul 2011 Additional trial centre and locations identified as reported by European Clinical Trials Database record.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
    • 08 May 2009 Additional lead trial centre identified as reported by Australian New Zealand Clinical Trials Registry record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top